Purdue Pharma Shutdown 2026, $5.544 Billion Criminal Sentence, $7.4 Billion Settlement and Purdue Personal Injury Trust Payments Explained
Purdue Pharma L.P., the maker of OxyContin, was sentenced in federal court on April 28, 2026 and ceased operating in its former form on May 1, 2026, when its Chapter 11 bankruptcy plan took effect. Its operations transferred to Knoa Pharma, LLC, a new public-benefit company. The personal injury trust created by the plan is…
